Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Fish and Richardson
Deloitte
Farmers Insurance
Chinese Patent Office
Merck
Argus Health
Fuji

Generated: February 20, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for ELIQUIS

« Back to Dashboard

Payment Methods and Pharmacy Types for ELIQUIS (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $329,371,692
INSIDE ANOTHER STORE $546,381,876
[disabled in preview] $2,018,572,630
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 484,260
INSIDE ANOTHER STORE 1,296,873
[disabled in preview] 3,816,183
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $876,120
MEDICARE $1,875,731,370
[disabled in preview] $1,021,283,648
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ELIQUIS
Drug Units Sold Trends for ELIQUIS

Annual Sales Revenues and Units Sold for ELIQUIS

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
ELIQUIS ➤ Try a Free Trial ➤ Try a Free Trial 2016
ELIQUIS ➤ Try a Free Trial ➤ Try a Free Trial 2015
ELIQUIS ➤ Try a Free Trial ➤ Try a Free Trial 2014
ELIQUIS ➤ Try a Free Trial ➤ Try a Free Trial 2013
Drug Name Revenues (USD) Units Year

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Johnson and Johnson
Farmers Insurance
Deloitte
Queensland Health
US Department of Justice
McKinsey
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.